MedPath

MR-Guided Laser Ablation of Prostate Bed Recurrences

Not Applicable
Withdrawn
Conditions
Prostate Tumors
Interventions
Procedure: MR-Guided Laser Ablation
Registration Number
NCT01743638
Lead Sponsor
Mayo Clinic
Brief Summary

The purpose of this study is to see if MR-guided laser ablation can effectively treat prostate tumor recurrences.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria
  • Patients with "biopsy proven" soft tissue tumor recurrences of prostate fossa referred to Urology and/or Interventional Radiology for treatment.
  • Surgery is not a desirable alternative therapy at the time of enrollment
  • Radiation therapy has failed or not indicated or can be safely postponed
  • Tumor size ≤ 5 cm at its largest diameter
  • Tumor does not encompass the rectal wall or external urethral sphincter
  • Performance status is ECOG 2 or better in adults
  • Patient is able to undergo MRI
Read More
Exclusion Criteria
  • Patients with pacemaker or defibrillator
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
MR-Guided Laser AblationMR-Guided Laser Ablation-
Primary Outcome Measures
NameTimeMethod
Measurement of target lesion(s) dimensions at 3-6 month imaging follow-up3-6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath